Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.
Journal: American journal of cancer research
Published: March 14, 2023
Prolonged Survival Using Outpatient Palliative Chemotherapy in Two Children With Refractory Acute Myelogenous Leukemia.
Journal: Journal of pediatric hematology/oncology
Published: August 03, 2022
Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors.
Journal: Frontiers in pharmacology
Published: July 27, 2021
Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis.
Journal: American journal of cancer research
Published: June 08, 2021
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
Journal: Neoplasia (New York, N.Y.)
Published: August 10, 2020
Showing 1-5 of 5
Last Updated: 09/26/2026